Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MASH/MetALD Consortium for the Assessment of Non-Invasive Testing in Monitoring Interventions, Treatment Response, and Major Liver-Related Outcomes

NCT06986447 is registered in ClinicalTrials.gov with HRI-MAIL-NIT as lead sponsor.

NCT NCT06986447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06986447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MASH/MetALD Consortium for the Assessment of Non-Invasive Testing in Monitoring Interventions, Treatment Response, and Major Liver-Related Outcomes
Lead sponsor
HRI-MAIL-NIT
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 25, 2025
Completion date
June 30, 2029
Enrollment
1,689 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

masld, masld - metabolic dysfunction-associated steatotic liver disease, masld/mash (metabolic dysfunction-associated steatotic liver disease / metabolic dysfunction-associated steatohepatitis), metabolic dysfunction-associated steatotic liver disease, metald